BioCentury
ARTICLE | Clinical News

Tricor fenofibrate: Post-marketing study data

May 17, 2010 7:00 AM UTC

A meta-analysis of 45,058 patients in 18 placebo-controlled trials showed that fibrate therapy led to a 10% relative risk reduction of major cardiovascular events (p=0.048) and a 13% relative risk red...